Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
Emory University
Emory University
National Institutes of Health Clinical Center (CC)
University of Chicago
Roswell Park Cancer Institute
University of Chicago
Jonsson Comprehensive Cancer Center